Abstract: Blood-brain barrier transport of the selective serotonin reuptake inhibitor and antidepressant, citalopram, was studied using monolayers of bovine brain microvessel endothelial cells (BMECs). This study provides for the first time, evidence of a transport mechanism for a selective serotonin reuptake inhibitor (SSRI). Carrier-mediated transport, efflux mechanisms, as well as inhibition of metabolizing enzymes of citalopram were investigated. Citalopram transport was saturable and temperaturedependent suggesting that passage of the drug across BMECs was mediated by a carrier mechanism. Since the apical to basolateral and basolateral to apical permeability coefficients were similar and cyclosporin A, a P-glycoprotein inhibitor, does not modify the transport of citalopram, it appeared that no active efflux systems were involved in this transport. Citalopram is only available as a racemic drug and its pharmacological effect resides mainly in the S-(+)-enantiomer. However, the passage of citalopram enantiomers across BMEC monolayers was not stereoselective. Finally, inhibition of the metabolizing enzymes of citalopram and monoamine oxidases did not modify the permeation of citalopram across BMECs. Collectively, our results suggested that citalopram crosses the blood-brain barrier via a non-stereoselective, bidirectional and symmetrical carrier-mediated mechanism without influences of active efflux mechanisms or monoamine oxidases.
Introduction
In general, few studies regarding the stereoselective levels of psychotropic drugs either in the brain or in the blood have been published. With the enantiomers of (E)-10-hydroxynortriptyline, evidence has strongly implicated a stereoselective, active transport of the molecule out of the cerebrospinal fluid [6] . In contrast, the difference between the brain levels of the enantiomers of fluoxetine may be the consequences of specific and stereoselective cerebral enzymatic activities [14] .
Citalopram (CIT), Figure 1 , is a selective serotonin reuptake inhibitor (SSRI) and antidepressant, which has recently been introduced as a racemic mixture [26] . The drug is well-absorbed with an absolute oral bioavailability of 80%. The pharmacological effect of CIT resides mainly in the S-(+)-enantiomer [18] . In humans, CIT is stereoselectively biotransformed mainly by N-demethylation to demethylcitalopram by cytochrome P450 (CYP) 2C19, 3A4 and 2D6 [27] but also by deamination to a propionic acid derivative (CIT-PROP) by monoamine oxidases (MAO) and aldehyde oxidase [29] .
The serum half-life of CIT is approximately 35 hours [35] . Knowledge of the biotransformation and elimination of CIT and other SSRIs has improved drug efficacy or safety and, in some cases, individualized drug treatment [8, 12] .
Although SSRI metabolism has been extensively studied in vivo and in vitro [5] , no data are available for the transport mechanisms into the brain. Indeed, the exchange of drugs between systemic circulation and the central nervous system is severely restricted by the so-called blood-brain barrier (BBB) [2] . The microvessels of the BBB consist of a single continuous layer of cerebral endothelial cells effectively sealed together by tight intercellular junctions. Cells surrounding the brain endothelium Rochat, B., Baumann, P., and Audus, K.L. (1999) Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium. Brain Res. 831, 229-236. PMID: 10412001. Publisher's official version: <http://dx.doi.org/10.1016/S0006-8993(99)01461-4> . Open Access version: http://kuscholarworks.ku.edu/dspace/.
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(i.e. neurons, astrocytes and pericytes), as well as the basal lamina, also contribute to the stability and the barrier characteristics of the brain microvessel cells (BMECs) [19] .
The presence of the efflux pump P-glycoprotein (Pgp) at the apical membrane of brain endothelial cells, compounds the picture of the BBB [36] . Pgp decreases the permeability across the BBB by effluxing many drugs and peptides back into the blood [2] . Moreover, brain endothelial cells contain a substantial volume of mitochondria, indicating that the BBB could contribute to signfficant MAO biotransformation of xenobiotics [16, 25] .
The purpose of this study was to evaluate CIT transport across the BBB using a simple, well characterized in vitro model of the brain endothelium: BMEC monolayers [1] . Specifically, carrier mechanisms, as well as Pgp and metabolism, were investigated as possible factors regulating the distribution of CIT across the blood-brain barrier.
Materials and Methods
Chemicals. Citalopram hydrobromide was obtained from Lundbeck (Copenhagen, Denmark). Serotonin, dopamine, L-tryptophan, cyclosporin A and rhodamine 123 were purchased from Sigma Chemical Company (St. Louis, MO). All other compounds used were of highest quality commercially available.
High performance liquid chromatography analysis (HPLC). Non-stereoselective HPLC analysis of CIT racemate was performed on a C18 analytical column coupled with a Shimadzu system (Shimadzu, Inc., Tokyo, Japan) consisting of LC-6A pump, a SIL-10A autoinjector and a SCL-10A controller. The injection volume was 200 µl. The Rochat, B., Baumann, P., and Audus, K.L. (1999) Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium. Brain Res. 831, 229-236. PMID: 10412001. Publisher's official version: <http://dx.doi.org/10.1016/S0006-8993(99)01461-4> . Open Access version: http://kuscholarworks.ku.edu/dspace/. 6 mobile phase consisted of 35% acetonitrile, 65 % triethylamine buffer 1% (vol/vol) adjusted with acetic acid to pH = 6. 1. The flow rate was 1.2 ml/min. Stereoselective analysis of CIT racemate was performed on a CHIROBIOTIC V analytical column (150 mm x 4.6 mm). The mobile phase was 99.885% methanol with 0.055% triethylamine and 0.060% acetic acid. The flow rate was 1.0 ml/min. The fluorescence detector (PerkinElmer LC 240) was coupled after the columns and set at 240 nm and 296 nm for excitation and emission wavelengths, respectively. Samples were directly injected into the column and quantitation was obtained after comparison of peak areas with a calibration curves. Calibration curves were linear between 25 nM and 30 µM. Samples were kept at 4°C for less than one month prior to HPLC analysis.
In a previous study [28] , the enantiomers of CIT showed high stability regarding temperature and in the solvents used above.
Cell culture. BMECs were isolated from gray matter of cerebral cortices by enzymatic digestion and subsequent centrifugation, and seeded into primary culture as detailed previously [1] . The 100 mm tissue cultures dishes (Coming Costar Corporation, Cambridge, MA) were pretreated with rat tail collagen and bovine fibronectin (Sigma Chemical Co., St. Louis, MO). Culture media consisted of a minimum of 45% essential media, 45% F-12 Ham nutrient mix (Gibco, Life Technologies, Grand Island, IL), 10 mM HEPES, pH 7.4, 13 mM sodium bicarbonate, 10% plasma-derived equine serum, 100 µg/ml heparin, 100 µg/ml streptomycin, 100 µg/ml penicillin G, 50 µg/ml polymixin B and 2.5 µg/ml amphotericin B (Sigma Chemical Co., St. Louis, MO).
Isolated BMECs were cultured at 37°C with 95% humidity and 5% CO 2 until confluent monolayers were formed (10 to 14 days). Cell surfaces facing the culture media, and those sealing the culture dishes, mimic apical and basolateral membranes of brain microvessel cells, respectively [1] . The purity of the isolated BMECs was monitored by periodic evaluation of the enrichment of enzyme markers, γ-glutamyl transpeptidase and alkaline phosphatase, and the endothelial origin confirmed by positive staining for Factor VIII antigen [1, 3] .
Transport studies. BMECs were seeded onto collagen-and fibronectin-coated, translucent, polycarbonate membranes (pore size 0.4 µm) placed in 100 mm tisssue culture dishes. Monolayer confluency was verified by inspection of the areas around the polycarbonate membranes using an inverted microscope. The basolateral side of the cells was defined as the side facing the collagen matrix. Once confluency was obtained, the membranes were carefully inserted in a horizontal Side-bi-Side diffusion apparatus (Crown Glass, Inc., Somerville, NJ) for transendothelial permeability studies.
The area of the diffusion membrane was 0.636 cm 2 . The donor and receiver chambers were filled with 3.0 ml of culture media and the temperature was maintained with an external circulating water bath at either 37°C or 4°C. The contents of each chamber were continuously stirred with Teflon coated magnetic stirred bars at the speed of 600 r/min driven by an external drive console (Crown Glass, Inc., Somerville, NJ). The apical to basolateral transport of CIT was studied with a 5 µM drug pulse added to the donor chamber. In some experiments, cyclosporin A (1 µM), serotonin (250 µM), dopamine (250 µM), tryptophan (250 µM), pargyline (100 µM), selegiline (50 nM) or clorgyline (50 nM) were added in both chambers at 50 min. In these cases, permeability coefficients were calculated for CIT permeation before and after the treatment. For cyclosporin A, pargyline, selegifine and clorgyline, a pre-incubation was performed for a specific time before the collection of the subsequent samples. A 200 µl sample was taken from the 
Results
Concentration-dependence of CIT transport. The time-dependent permeation of CIT across BMEC monolayers was determined using concentrations ranging from 1 µM to 1000 µM.
The flux of CIT across BMEC monolayers for 30 min was linear over the concentration range examined at 37°C (data not shown). Figure 2 illustrates the concentration dependence of the apical to basolateral transport of CIT across BMEC monolayers at 37°C. The flux (Figure 2A) and the apparent permeability coefficients ( Figure 2B ) for CIT passage across BMEC monlayers was a saturable process at concentrations higher than 100 µM. The apparent permeability Rochat, B., Baumann, P., and Audus, K.L. (1999) Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium. Brain Res. 831, 229-236. PMID: 10412001. Publisher's official version: <http://dx.doi.org/10.1016/S0006-8993(99)01461-4> . Open Access version: http://kuscholarworks.ku.edu/dspace/. 9 coefficient for CIT passage across the BMEC monolayers was significantly greater than for sucrose (data not shown), a marker for paracellular leakage of the monolayers. Collectively, these results argued for a carrier-mediated mechanism for CIT transport across BMECs.
Michaelis-Menten parameters, K m and J max values, were determined to be 487 µM and 7.4 nmol/min, respectively.
Temperature dependence of CIT transport. The effect of temperature on the apical to basolateral permeation of CIT (5 µM) across the BMECs is presented in Figure 3A .
After 
Discussion
In BMECs, the polarity of transport mimics the blood to brain and brain to blood passage for some substances [1] . In the present study, we provided evidence that citalopram was transported across brain microvessel endothelium via a saturable mechanism in the apical-to-basolateral direction.
Consistent with carrier-mediated mechanisms versus passive diffusion, the passage of CIT across the cells was extremely sensitive to low temperature. However, it also appeared that the process was not selective for S-(+)-CIT, the pharmacologically active enantiomer, suggesting that the transport process was non-stereoselective.
The absence of stereoselectivity is associated with carrier mechanisms of broad specificity such as the unidirectional Pgp efflux mechanism [30] and asymmetry in transport is reflective of such unidirectional, polyspecific efflux or uptake mechanisms [1] . In this study, the transport of CIT and the representative PgP substrate, rhodamine 123 [13] , across BMECs was assayed in both directions. Apical to basolateral and basolateral to apical transport of CIT were similar and unaltered in the presence of a known Pgp inhibitor, cyclosporin A [13] . By contrast, the apical to basolateral transport of our positive control, rhodamine 123, was strongly impaired by the efflux pump, Pgp and modified on exposure to cyclosporin A. The lack of asymmetric transport and the absence of a sensitivity to cyclosporin A strongly suggested that CIT is not a substrate of Pgp or known alternative asymmetric active efflux systems like the multidrug resistant associated protein (MRP), a recently described efflux mechanism in brain endothelium [24] . The relatively poor lipophilicity of CIT [4] , a feature of most Pgp and MRP substrates [33] , would further suggest that the drug would not necessarily fit the physicochemical profile of a substrate for these typical efflux mechanisms. Therefore, nonstereoselective, active, and unidirectional efflux mechanisms do not seem to be involved in regulating CIT distribution across brain endothelium.
Bidirectional, saturable transport is a characteristic of non-energy requiring facilitated diffusion mechanisms at the blood-brain barrier [2] and appears likely to mediate CIT distribution across BMEC monolayers.
Although binding studies have shown that the tricyclic antidepressant imipramine and the SSRI, paroxetine, have low and high binding sites on isolated porcine microvessels [10, 11] , these binding sites remain to be fully characterized and could be either ATP dependent transporters or ATP-independent carriers. The imipramine binding site on BMECs is believed to label the serotonin transporter [11] .
Citalopram has been shown to competitively inhibit serotonin uptake and transport at submicromolar concentrations and is therefore, considered a very effective and specific serotonin uptake inhibitor [7, 17, 35] . However, we were not able to establish significant decreases in the transport of CIT across BMECs in the presence of either serotonin or L-tryptophan. Moreover, CIT did not inhibit dopamine transport. Sufficiently high expression of carriers on BMEC membranes, high maximum uptake rate (J max ) and/or participation of various carriers may explain the apparent lack of inhibitory effects of potential endogenous substrates on CIT transport at these concentrations. The low affinity and absence of significant competition with other potential substrates at the concentrations here would also be consistent with the observations for transport properties of the high capacity, polyspecific cationic carriers that are present in BMECs and other tissues [21] . Some authors have suggested that a panel of stably transfected cell lines expressing specific transporters could be an appropriate tool for this purpose [30] to identify more potent and specific inhibitors for such mechanisms. Using this approach, Breidert et al. [9] , was recently able to demonstrate in such a constructed cell line stably expressing
OCT1r that transported several substrates in a saturable fashion, including norepinephrine, dopamine, and serotonin. However, the transport of the norepinephrine, dopamine, and serotonin by the OCT1r expressing cells was resistant to specific inhibitors such as desipramine, cocaine, and CIT, respectively.
Our results were consistent with this observation and could be suggestive of the involvement of a polyspecific carrier in CIT transport. The absence of effects of potential inhibitors of CIT transport underlines the difficulties in identifying and kinetically characterizing the involvement of polyspecific carriers involved in the uptake and transport of drugs by cells.
Brain microvessel endothelium contains a very low level of cytochrome P-450 and, in contrast, contains high quantities of MAO type A or type B, metabolizing-isozymes found in mitochondrial membranes [25] . It appears that the levels of MAO type A in BMECs approach those of the gray matter but in contrast, MAO type B activity is a few times lower compared to activities of gray matter [3] . Some authors have suggested that microvessels should be considered as a potential site of inactivation of some neurotransmitters or drugs [3, 20, 25] . For instance, the transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin, across primary cultures of BMECs seems to be restricted by oxidation mediated by MAO [32] . In the presence of pargyline, seleguine, or clorglyine, the passage of MPTP increased significantly and the appearance of its oxidative metabolites was decreased. A combination of SSRI and MAO inhibitors have been shown to produce more adverse effects than SSRI alone [22] . Considering that CIT is biotransformed by both MAO type A and type B [29], it was interesting to evaluate the inhibitory effect of MAO activities on CIT transport across BMECS. MAO inhibition obtained with pargyline, selegiline, or clorgyline, did not modify the apparent permeability coefficients for CIT. Our results suggested that CIT metabolizing enzymes would not be involved in the passage of CIT across the BBB. Moreover, the high permeability coefficient of CIT, in contrast to Pgp substrates, was consistent with the probable insignificant role of MAO for CIT deliverance at the BBB. Indeed, some authors have suggested that reducing the rate of the transport of cyclosporin A across Caco-2 cells increases its biotransformation rate [15] . Similar to CIT, pargyline has been observed to not modify dopamine uptake in perfused brains of guinea pigs [23] . It was suggested that BBB uptake of dopamine was independent of MAO type B, a dopamine metabolizing enzyme. Taking into consideration these data, interindividual differences of cerebral levels of the CIT enantiomers and other SSRIs (e.g., fluoxetine) might result from its stereoselective metabolism in the liver and in the brain [14, 34] , rather than due to stereoselective transport or biotransformation localized at the BBB.
To conclude, this study provides for the first time, evidence of transport mechanisms of a SSRI antidepressant across the BBB using monolayers of BMECS. CIT seems to cross the blood-brain barrier via a non-stereoselective, bidirectional and saturable carrier-mediated mechanism with no influence of either active efflux mechanisms (e.g. Pgp) or monoamine oxidases.
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